ATE380249T1 - Stabiele transfizierte zellen zum auffinden von wirkstoffen, die die mrna stabilität beeinflussen - Google Patents
Stabiele transfizierte zellen zum auffinden von wirkstoffen, die die mrna stabilität beeinflussenInfo
- Publication number
- ATE380249T1 ATE380249T1 AT99962013T AT99962013T ATE380249T1 AT E380249 T1 ATE380249 T1 AT E380249T1 AT 99962013 T AT99962013 T AT 99962013T AT 99962013 T AT99962013 T AT 99962013T AT E380249 T1 ATE380249 T1 AT E380249T1
- Authority
- AT
- Austria
- Prior art keywords
- mrna stability
- active substances
- transfected cells
- stable transfected
- affect mrna
- Prior art date
Links
- 108020004999 messenger RNA Proteins 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 230000014509 gene expression Effects 0.000 abstract 2
- 108700008625 Reporter Genes Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000003571 reporter gene assay Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pyrane Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9828709.7A GB9828709D0 (en) | 1998-12-24 | 1998-12-24 | Assay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE380249T1 true ATE380249T1 (de) | 2007-12-15 |
Family
ID=10845082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99962013T ATE380249T1 (de) | 1998-12-24 | 1999-12-23 | Stabiele transfizierte zellen zum auffinden von wirkstoffen, die die mrna stabilität beeinflussen |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20150176088A1 (de) |
| EP (1) | EP1141358B1 (de) |
| JP (1) | JP2002541767A (de) |
| AT (1) | ATE380249T1 (de) |
| AU (1) | AU776604C (de) |
| CA (1) | CA2356621C (de) |
| DE (1) | DE69937689T2 (de) |
| DK (1) | DK1141358T3 (de) |
| ES (1) | ES2299273T3 (de) |
| GB (1) | GB9828709D0 (de) |
| PT (1) | PT1141358E (de) |
| WO (1) | WO2000039314A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000038674A1 (en) | 1998-12-24 | 2000-07-06 | Novation Pharmaceuticals Inc. | COMPOUNDS WHICH AFFECT mRNA STABILITY AND USES THEREFOR |
| US7598079B2 (en) | 1998-12-24 | 2009-10-06 | Novation Pharmaceuticals, Inc. | Assay for identifying compounds which affect stability of mRNA |
| JP2004530425A (ja) * | 2001-03-09 | 2004-10-07 | ジーン ストリーム プロプライエトリー リミティッド | 新規な発現ベクター |
| CN1653059A (zh) | 2002-03-08 | 2005-08-10 | 卫材株式会社 | 用作医药品的大环化合物 |
| US7915306B2 (en) | 2002-03-08 | 2011-03-29 | Eisai Co., Ltd. | Macrocyclic compounds useful as pharmaceuticals |
| JP2005529590A (ja) | 2002-04-17 | 2005-10-06 | ノバルティス アクチエンゲゼルシャフト | ＡＲＥ含有ｍＲＮＡとＨｕＲタンパク質の結合のインヒビターの同定方法 |
| JP4528623B2 (ja) * | 2002-09-16 | 2010-08-18 | プロメガ コーポレイション | 迅速分解性レポーター融合タンパク質 |
| US8460864B2 (en) | 2003-01-21 | 2013-06-11 | Ptc Therapeutics, Inc. | Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same |
| US9068234B2 (en) | 2003-01-21 | 2015-06-30 | Ptc Therapeutics, Inc. | Methods and agents for screening for compounds capable of modulating gene expression |
| US8426194B2 (en) | 2003-01-21 | 2013-04-23 | Ptc Therapeutics, Inc. | Methods and agents for screening for compounds capable of modulating VEGF expression |
| US8076352B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Administration of carboline derivatives useful in the treatment of cancer and other diseases |
| US7767689B2 (en) | 2004-03-15 | 2010-08-03 | Ptc Therapeutics, Inc. | Carboline derivatives useful in the treatment of cancer |
| US8076353B2 (en) | 2004-03-15 | 2011-12-13 | Ptc Therapeutics, Inc. | Inhibition of VEGF translation |
| UA92317C2 (ru) | 2004-03-15 | 2010-10-25 | Пи-Ти-Си ТЕРАПЬЮТИКС, ИНК. | Производные карболина, пригодные для ингибирования развития кровеносных сосудов |
| US8283115B1 (en) | 2007-06-20 | 2012-10-09 | Ptc Therapeutics, Inc. | Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation |
| US8283116B1 (en) | 2007-06-22 | 2012-10-09 | Ptc Therapeutics, Inc. | Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation |
| KR101667960B1 (ko) | 2007-07-25 | 2016-10-20 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 암 치료에서 이용하기 위한 멀티키나아제 억제제 |
| CA2996064C (en) | 2015-08-18 | 2024-02-13 | Novation Pharmaceuticals Inc. | Benzopyran derivatives and uses thereof |
| JP7019590B2 (ja) | 2016-03-31 | 2022-02-15 | バークレー ライツ，インコーポレイテッド | 核酸安定化試薬、キット、及びその使用方法 |
| CN116426610B (zh) * | 2023-06-08 | 2024-01-05 | 启辰生生物科技(珠海)有限公司 | 一种LC-MS法准确定量mRNA加帽效率的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6174666B1 (en) * | 1992-03-27 | 2001-01-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method of eliminating inhibitory/instability regions from mRNA |
| CA2191583C (en) * | 1994-06-07 | 2007-03-27 | Engin Ozkaynak | Methods and compositions for modulating morphogenic protein expression |
| US5731343A (en) * | 1995-02-24 | 1998-03-24 | The Scripps Research Institute | Method of use of radicicol for treatment of immunopathological disorders |
| AU766146B2 (en) * | 1998-05-26 | 2003-10-09 | University Of Medicine And Dentistry Of New Jersey | System for reproducing and modulating stability and turnover of RNA molecules |
-
1998
- 1998-12-24 GB GBGB9828709.7A patent/GB9828709D0/en not_active Ceased
-
1999
- 1999-12-23 EP EP99962013A patent/EP1141358B1/de not_active Expired - Lifetime
- 1999-12-23 AT AT99962013T patent/ATE380249T1/de not_active IP Right Cessation
- 1999-12-23 DE DE69937689T patent/DE69937689T2/de not_active Expired - Lifetime
- 1999-12-23 DK DK99962013T patent/DK1141358T3/da active
- 1999-12-23 JP JP2000591204A patent/JP2002541767A/ja active Pending
- 1999-12-23 AU AU18522/00A patent/AU776604C/en not_active Ceased
- 1999-12-23 PT PT99962013T patent/PT1141358E/pt unknown
- 1999-12-23 ES ES99962013T patent/ES2299273T3/es not_active Expired - Lifetime
- 1999-12-23 WO PCT/CA1999/001235 patent/WO2000039314A1/en not_active Ceased
- 1999-12-23 CA CA2356621A patent/CA2356621C/en not_active Expired - Lifetime
-
2014
- 2014-12-10 US US14/566,621 patent/US20150176088A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20150176088A1 (en) | 2015-06-25 |
| AU1852200A (en) | 2000-07-31 |
| CA2356621A1 (en) | 2000-07-06 |
| DK1141358T3 (da) | 2008-03-31 |
| AU776604C (en) | 2005-05-12 |
| GB9828709D0 (en) | 1999-02-17 |
| WO2000039314A1 (en) | 2000-07-06 |
| ES2299273T3 (es) | 2008-05-16 |
| CA2356621C (en) | 2013-03-26 |
| EP1141358A1 (de) | 2001-10-10 |
| AU776604B2 (en) | 2004-09-16 |
| DE69937689T2 (de) | 2008-08-28 |
| DE69937689D1 (de) | 2008-01-17 |
| JP2002541767A (ja) | 2002-12-10 |
| PT1141358E (pt) | 2008-03-17 |
| EP1141358B1 (de) | 2007-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE380249T1 (de) | Stabiele transfizierte zellen zum auffinden von wirkstoffen, die die mrna stabilität beeinflussen | |
| DE69822206D1 (de) | Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen | |
| TR200002446T2 (tr) | Fosfolipaz enzimlerinin inhibitörleri | |
| DE60322880D1 (de) | Einfache katalytische dna-biosensoren für ionen auf grundlage von farbveränderungen | |
| NO20025402L (no) | Modifiserte ES-celler og ES-cellespesifikke gener | |
| DE69606352D1 (de) | Additvthaltige Kathoden für elektrochemische Zellen | |
| WO2003093469A3 (en) | Methods for delivering nucleic acid molecules into cells and assessment thereof | |
| WO2004065581A3 (en) | Transposon-insulator element delivery systems | |
| WO2002029113A3 (en) | Methods for monitoring multiple gene expression | |
| DE69906574T2 (de) | Vorrichtung zum züchten von organischen zellen und erforschung ihrer elektrophysiologischen aktivität und dabei verwendete membran | |
| EP1131333A4 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| EP0599651A3 (de) | Bioreaktor für die Perfusionskultur von Zellen. | |
| ATE346156T1 (de) | Umkehrtransfektionsverfahren | |
| DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| TR199800046A3 (tr) | Aktif maddeler yaratilmasi için nükleik asit olusumu. | |
| DE69930837D1 (de) | Verwendung von katalysatoren in ventilgeregelten stand-by bleisäure zellen | |
| BR9811006A (pt) | Sequência de dna, cassete de expressão, uso do mesmo, processo para transformar uma planta, planta com um elevado teor em vitamina e, processo para gerar plantas com um elevado teor em vitamina e e para gerar plantas com elevada resistência a inibidores de hppd, sistema de teste, subtância herbicamente ativa, uso de uma planta, e, planta com elevada resistência a inibidores de hppd | |
| ATE331802T1 (de) | Sequenz-spezifische dna-rekombination in eukaryotischen zellen | |
| Anas et al. | SIT1 is a betaine/proline transporter that is activated in mouse eggs after fertilization and functions until the 2-cell stage | |
| DE59813413D1 (de) | Optimierung von Zellen für die endogene Genaktivierung | |
| Lau et al. | Tissue-specific and imprinted epigenetic modifications of the human NDN gene | |
| WO2003095608A3 (en) | Dna microarrays comprising active chromatin elements and comprehensive profiling therewith | |
| DE69942063D1 (de) | Antagonisten von 'hedgehog' und 'patched' zur inhibierung des wachstums und der differenzierung von zellen und geweben, als auch deren verwendungen | |
| ATE267396T1 (de) | Identifizierung von zellen während kinetischer versuchsreihen | |
| DE69713759D1 (de) | Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1141358 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |